MIMIT IS 10
On Wednesday 7th November 2018, MIMIT celebrated its 10 year anniversary in Manchester’s landmark Citylabs.
Welcoming an audience of clinicians, academics, industry leads, policy makers, collaborators and supporters, Professor Jackie Oldham (MIMIT Director) showcased the incredible impact that MIMIT has spearheaded over the last decade, including £31.2m of commercial funding leverage, 5 licenses, 100 academic publications, 4 spin out companies, 83 jobs created and 5 million patient benefits in Greater Manchester already (with many more to come).
MIMIT clinical Ambassadors John New (Consultant Diabetologist, Salford Royal Foundation Trust and North West e-Health Director Salford Lung Study) and Peter Alexander (Consultant in Anaesthesia and Intensive Care Medicine, Manchester Foundation Trust) joined MIMIT academic Ambassadors Emma Stanmore (Senior Lecturer, School of Health Sciences, University of Manchester) and Alex Casson (Senior Lecturer in Sensing, Imaging and Signal Processing, University of Manchester), discussing why they are part of MIMIT, the integral relationships the partnership provides and the collaboration, opportunities and successes that have arisen as a result.
MIMIT was also supported by video messages from the original CIMIT founders, John Parrish and Colleen Kigin, showcasing just how far the model has come.
Guests also had an opportunity to view finalised projects that originated as MIMIT unmet needs, such as Pelviva (a pelvic floor trainer for the treatment of bladder leakage in women).
Finally, the evening culminated in thanks to Professor Oldham and the late Keith Chantler for their vision, as-well as MIMIT’s collaborators, ambassadors, investors and supporters.
PELVIVA SHORTLISTED FOR ‘PRODUCT OF THE YEAR’
Pelviva (a disposable, clinically effective, discreet and easy-to-use pelvic floor muscle re-trainer for the treatment of bladder leakage in women) has been shortlisted for ‘Product of the Year’ at the prestigious Bionow Awards 2018.
The Pelviva project originated as a MIMIT unmet need for female bladder leakage and the subsequent research and evolved partnerships facilitated by MIMIT resulted in a spin out company for the Pelviva product.
One in three women experience bladder leaks but after 12 weeks of regularly using Pelviva, 84% of women reported improved bladder control (as part of a single blind randomised control trial).